scholarly article | Q13442814 |
P356 | DOI | 10.1007/BF02942949 |
P698 | PubMed publication ID | 23604762 |
P2093 | author name string | M Gekle | |
C Sauvant | |||
H Holzinger | |||
P2860 | cites work | Mammalian MAP kinase signalling cascades | Q28204140 |
The role of mitogen-activated protein (MAP) kinase in breast cancer | Q30308930 | ||
Drug uptake systems in liver and kidney | Q35137526 | ||
Ochratoxin A in human blood in relation to nephropathy in Tunisia | Q39198684 | ||
Human ochratoxicosis and nephropathy in Egypt: a preliminary study | Q39567391 | ||
The role of ochratoxin A as a possible cause of Balkan endemic nephropathy and its risk evaluation | Q40834119 | ||
Constitutively active mitogen-activated protein kinase kinase MEK1 disrupts morphogenesis and induces an invasive phenotype in Madin-Darby canine kidney epithelial cells. | Q40950403 | ||
Ochratoxin A-induced stimulation of extracellular signal-regulated kinases 1/2 is associated with Madin-Darby canine kidney-C7 cell dedifferentiation. | Q54147741 | ||
Requirement of Erk, but not JNK, for arsenite-induced cell transformation | Q63561118 | ||
Experimental porcine nephropathy. Changes of renal function and structure induced by ochratoxin A- contaminated feed | Q68790531 | ||
P433 | issue | 2 | |
P304 | page(s) | 118-123 | |
P577 | publication date | 2003-06-01 | |
P1433 | published in | Mycotoxin Research | Q27723662 |
P1476 | title | Inhibition of the mitogen activated protein kinase ERK1/2 amplifies ochratoxin A toxicity in the proximal tubule of the kidney | |
P478 | volume | 19 |